Joshua Lerman first learned about prostate cancer at 27 years old, when his father fought, and ultimately lost, his battle with the disease in just two short years. He promised then and there that he would do everything he could to continue to spread education and awareness of the disease – both for himself, and for his son.
He began annual exams and PSA testing at 35 due to his family history, continuing to research and speak out about the disease. In March of 2016 Joshua’s PSA tripled in just a twelve month time span, which combined with his family history, was troubling. He was given an immediate Fusion Targeted Biopsy and MRI, and though there were some concerns with only one positive core, he was eventually diagnosed with prostate cancer. After researching his options, Joshua decided on HIFU (High Intensity Focused Ultrasound), a new treatment just approved by the FDA for use in the United States. Although his insurance did not cover the procedure, he felt the cost was worth it.
“Research everything. I can’t tell you how much I have continued to learn as I have gone through this process. It is a difficult subject for men, but an important one.”
Joshua now spends time helping to educate men about prostate cancer and the importance of early detection. He frequently shares his story to increase awareness, sends mass emails and announcements to his networks, and speaks to the media. Joshua discovered ZERO’s website during his journey and now plans to become a ZERO advocate on behalf of other men. Though the subject is difficult for men to address – which presents a challenge to his work on increased awareness – he continues to urge men to be tested early and to push for increased education.
“My initial education about this disease was to watch my father fight, and lose his battle, to prostate cancer in only two years. I promised myself that I would do everything I could to share education and awareness with as many men as possible. Early detection is key.”